Table 4: Multivariate analysis to determine relationship of outcome to clinical parameters and molecular subtype classifications in the TCGA-dataset.
In all analyses we performed Cox Proportional Hazards Model with stepwise selection procedure to determine the final model that accurately describes the outcome. The parameters included in each analysis were: Age, sex, T-stage, N-stage, M-stage, LVI, and subtype classification. Only significant parameters based on Wald’s test with overall hazard ratio (HR) and 95% CI are shown.
TCGA dataset OS Indicator | ||||||||
---|---|---|---|---|---|---|---|---|
MCG-1 | Consensus | TCGA-2017 | Lund-Taxonomy | |||||
Parameter | P value | HR; 95% CI | P value | HR; 95% CI | P value | HR; 95% CI | P value | HR; 95% CI |
LVI | 0.003 | 2.7; 1.4 – 5.3 | 0.003 | 2.7; 1.4 – 5.3 | 0.016 | 2.3; 1.2 – 4.7 | 0.003 | 2.7; 1.4 – 5.3 |
Subtype Classification | 0.045 | 4.4; 1.1 – 16.5 | ||||||
TCGA dataset RFS Indicator | ||||||||
MCG-1 | Consensus | TCGA-2017 | Lund-Taxonomy | |||||
Parameter | P value | HR; 95% CI | P value | HR; 95% CI | P value | HR; 95% CI | P value | HR; 95% CI |
N-stage | 0.039 | 2.1; 1.04 – 4.2 | 0.039 | 2.1; 1.04 – 4.2 | 0.039 | 2.1; 1.04 – 4.2 | 0.039 | 2.1; 1.04 – 4.2 |
Note: Analysis of only HG specimens yields the same values.